The Trump administration’s decision to delay key funding approvals has put critical HIV research programs at risk, raising concerns among public health experts and advocates. Federal grants supporting prevention efforts, treatment development, and community outreach could face disruptions if the delays persist, potentially undermining progress in combating the disease. The move comes amid ongoing debates over budget priorities and public health funding, leaving researchers and organizations scrambling to secure alternative resources. Without timely financial support, long-standing initiatives aimed at reducing HIV transmission and improving care access may stall.
Trump Administration Delays Threaten Funding for HIV Research The New York Times
